This test is most useful if any of these apply to you.
If you react to apples but standard testing has not made the picture clear, this test looks at one specific apple protein called Mal d 2 to see if your immune system has flagged it. Most apple reactions come from a different protein, Mal d 1, so this measurement is best understood as a niche piece of a larger puzzle rather than a standalone answer.
The honest framing matters here. Mal d 2 sensitization is uncommon, and when it shows up on its own, it tends to be quiet rather than dangerous. This test gives you a research-grade window into a less-studied corner of apple allergy biology, useful when you want a complete component profile alongside the more established markers.
This test detects IgE (immunoglobulin E) antibodies in your blood that are specifically built to recognize Mal d 2, a thaumatin-like protein found in apples. IgE is the antibody class your immune system uses to flag things it considers threats, and finding IgE against an apple protein means your body has registered that protein as something to react to. Mal d 2 belongs to a broader family of plant defense proteins called thaumatin-like proteins (pathogenesis-related family PR-5), which are stable, abundant structural proteins in apple tissue, though they are only a minor allergen clinically.
Having this antibody in your blood is called sensitization. Sensitization is not the same as a clinical allergy. You can carry the antibody and never have a symptom when you eat an apple. The result is one piece of information that needs to be combined with what actually happens to your body when you eat apples.
Across diverse populations, Mal d 2 IgE is rare. In a Polish pediatric study using a molecular allergy panel on 3,715 children, only about 0.27% of children had detectable Mal d 2 IgE, making it one of the least frequently flagged molecules in the entire panel. In a large Italian cohort of 7,176 allergic patients, sensitization to thaumatin-like proteins (including Mal d 2) was found in roughly 1.9% of patients overall (137 out of 7,176). A Chinese apple allergy study notes that Mal d 2 sensitization is around 5%, and the authors concluded Mal d 2 is not a major apple allergen.
For context, the dominant apple allergen Mal d 1 shows much higher sensitization rates in apple-allergic cohorts, ranging from roughly 79% in Mexican pediatric patients to about 85% in Northern Chinese patients, and is the dominant allergen across most Northern European populations. So Mal d 2 sits firmly in minor-allergen territory, which shapes how the result should be interpreted.
A positive Mal d 2 IgE result means your immune system has produced antibodies against this specific apple protein. In the large Italian cohort, isolated Mal d 2 sensitization (without antibodies to other plant proteins) was described as generally clinically silent, with most measurable IgE at low levels (mean around 0.61 kUA/L). When symptoms did occur in TLP-sensitized patients, they were usually driven by co-existing antibodies to other plant proteins, not by Mal d 2 itself.
In statistical analysis of that cohort, the level of TLP-specific IgE did not independently predict whether someone had moderate or severe symptoms (ROC AUC roughly 0.51 to 0.61). In plain terms, a positive Mal d 2 result alone does not reliably tell you that an apple will cause a serious reaction.
Component testing for apple allergy is anchored by Mal d 1 (the major birch-pollen-related allergen) and Mal d 3 (a lipid transfer protein that, in some regions, can signal risk of systemic reactions and reactions to other fruits, nuts, or legumes). The papers that evaluate diagnostic performance with sensitivity, specificity, and cutoffs concentrate on Mal d 1, not Mal d 2, because Mal d 2 is rare and adds little independent information for most patients.
| Apple Component | Typical Role | What It Adds |
|---|---|---|
| Mal d 1 (PR-10) | Major allergen tied to birch pollen cross-reactivity | Best single marker for apple allergy in most populations |
| Mal d 2 (thaumatin-like) | Minor, infrequent allergen | Usually clinically quiet when present alone |
| Mal d 3 (lipid transfer) | Region-dependent, can signal systemic reactions | Linked to risk of broader fruit, nut, or legume reactivity in some populations |
What this means for you: if you are working up suspected apple allergy, Mal d 2 is one slice of a fuller picture. Pairing it with Mal d 1 and Mal d 3 testing, plus a careful history of what foods cause what symptoms, gives a far more useful read than any single component on its own.
Specific IgE testing for any food allergen is sensitive to a handful of factors that can throw off interpretation. Total IgE levels can fluctuate with recent illness or broader immune activity, which is more clearly documented for whole-extract testing than for individual components. Some allergen-specific IgE levels also fluctuate over time as exposure changes seasonally, particularly for cross-reactive allergens connected to pollen. And because Mal d 2 sensitization is uncommon and usually low-titer, small assay variations can move borderline results across thresholds.
The biggest practical pitfall is conceptual rather than analytical. Mal d 2 IgE measures sensitization, not symptoms. People can produce these antibodies and eat apples without trouble. The reverse is also possible. One study found patients with classic birch-related apple symptoms who had no detectable serum IgE to Mal d 1, meaning negative blood results can miss clinically relevant sensitization. Treat the number as one input, not a verdict.
A single Mal d 2 IgE reading is a snapshot. Specific IgE levels can shift over months and years, particularly when you change exposures, complete allergen immunotherapy, or develop new cross-reactivities. If you are using this test as part of a broader allergy workup, a baseline now and a retest in 6 to 12 months gives you a trajectory rather than an isolated data point.
If you are pursuing immunotherapy or actively adjusting your diet, tracking how Mal d 2 IgE changes alongside Mal d 1, Mal d 3, and your symptoms can help you see whether the underlying immune pattern is shifting. Because Mal d 2 is a research-grade marker without standardized clinical cutpoints, your own personal trend is more meaningful than any one absolute number.
If your Mal d 2 IgE comes back positive, the next step is not to remove apples from your diet on the basis of the number alone. The most informative pairings are a full apple component panel and a careful symptom diary that records what you ate, in what form (raw, cooked, peeled), and what happened afterward. A fuller panel includes Mal d 1, Mal d 2, Mal d 3, and ideally Mal d 4, a profilin protein that often signals broader pollen-related cross-reactivity to fruits and vegetables.
Patterns matter more than thresholds. Isolated Mal d 2 positivity with no symptoms is usually best monitored rather than acted on. Mal d 2 positivity alongside Mal d 1 or Mal d 3, combined with real-world reactions, is a reason to involve an allergist who can interpret the full profile and decide whether a supervised food challenge or further testing is appropriate. A skin prick test using fresh apple is another companion test that can clarify clinically relevant sensitization.
Evidence-backed interventions that affect your Apple (Mal d 2) IgE level
Apple (Mal d 2) IgE is best interpreted alongside these tests.
Apple (Mal d 2) IgE is included in these pre-built panels.